4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Windlas Biotech Limited (WINDLAS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Dehradun, India with about 1,385 employees. Its market capitalization is roughly ₹18 billion. In the fiscal year ended 2026-03-31, WINDLAS reported ₹9.0B in revenue and ₹665M in net income.
Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services.
Interactive charts & full statements → Open the WINDLAS valuation workbench →
| Income statement | TTM → 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹9.4B | ₹9.0B | ₹7.6B | ₹6.3B | ₹5.1B | — |
| Gross Profit | ₹3.6B | ₹3.4B | ₹2.8B | ₹2.3B | ₹1.9B | — |
| Operating Income (EBIT) | ₹744M | ₹742M | ₹666M | ₹647M | ₹479M | — |
| Net Income | ₹664M | ₹665M | ₹610M | ₹582M | ₹426M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹2.5B | ₹2.4B | ₹2.3B | ₹2.2B | ₹2.1B | — |
| Gross Profit | ₹954M | ₹914M | ₹896M | ₹854M | ₹804M | — |
| Operating Income (EBIT) | ₹195M | ₹173M | ₹167M | ₹210M | ₹191M | — |
| Net Income | ₹176M | ₹160M | ₹150M | ₹178M | ₹177M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹122M) | (₹115M) | (₹83M) | (₹76M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹9.1B | ₹7.6B | ₹6.3B | ₹5.3B | — |
| Total Liabilities | ₹3.3B | ₹2.5B | ₹1.8B | ₹1.3B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WINDLAS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms